The cyclin D1 gene encodes the regulatory subunit of a holoenzyme that phosphorylates and inactivates the retinoblastoma protein, thereby promoting cell-cycle progression. Cyclin D1 is overexpressed in hematopoetic and epithelial malignancies correlating with poor prognosis and metastasis in several cancer types. Because tumor-associated macrophages have been shown to enhance malignant progression and metastasis, and cyclin D1-deficient mice are resistant to oncogene-induced malignancies, we investigated the function of cyclin D1 Ϫ/Ϫ bone marrow-derived macrophages. Cyclin D1 deficiency increased focal complex formation at the site of substratum contact, and enhanced macrophage adhesion, yielding a flattened, circular morphology with reduced membrane ruffles. Migration in response to wounding, cytokinemediated chemotaxis, and transendothelial cell migration of cyclin D1 Ϫ/Ϫ bone marrowderived macrophages were all substantially reduced. Thus, apart from proliferative and possible motility defects in the tumor cells themselves, the reduced motility and invasiveness of cyclin D1 Ϫ/Ϫ tumor-associated macrophages may contribute to the tumor resistance of these mice.
INTRODUCTION
Leukocyte motility is essential for normal development and immune function. Colony stimulating factor-1 (CSF-1) is the primary regulator of mononuclear phagocyte survival, proliferation, and differentiation (Stanley et al., 1983 (Stanley et al., , 1997 Cecchini et al., 1994) . Macrophage motility is also stimulated by CSF-1 (Boocock et al., 1989; Allen et al., 1997) and is associated with reorganization of the actin cytoskeleton and focal complex formation (Allen et al., 1997; Vanhaesebroeck et al., 1999) . Guided migration of macrophages involves sequential protrusion of filopodia and lamellipodia at the leading edge, focal complex-dependent adhesion of the leading edge to substratum, and cytoplasmic actomyosin contraction and detachment of the trailing uropod (Sheetz et al., 1999; Jones, 2000) . Coordinating sequential integration of these events, and dynamic remodeling of cellular focal complexes with the substratum are essential for sustained migration toward a chemoattractant (Jones, 2000) . Because macrophages are specialized locomotory cells, the organization of their actin cytoskeleton and integrin-mediated cell-substratum contacts is distinct from that of fibroblasts. Instead of stress fibers, macrophages contain thinner F-actin cables that form upon CSF-1 stimulation and rarely arise from focal complexes (Allen et al., 1997; Pixley et al., 2001) . Macrophage focal complexes contain proteins found in fibroblast focal contacts, including focal adhesion kinase (FAK), paxillin, vinculin, and ␤1 integrin (Allen et al., 1997) , but are considerably smaller and fewer in number.
Apart from their role in development and immune function, motile macrophages may also enhance the malignant potential of tumors. They are recruited into mammary gland carcinomas (Liotta and Kohn, 2001; Kacinski, 2002) and, in the absence of such tumor-associated macrophages, metastatic progression of mammary gland tumors is profoundly reduced in Csf1 op /Csf1 op mice lacking CSF-1 expression (Lin et al., 2001) . Furthermore, in a human malignant tumor xenograft model, CSF-1 antisense oligonucleotides suppress tumor growth (Aharinejad et al., 2002) . These studies suggest that CSF-1-regulated macrophages promote neoplastic progression and metastatic spread and imply a causal link between tumor-associated macrophages and the malignant potential of breast epithelial cells.
Cyclin D1, a regulator of cell-cycle transition through G 1 phase, was cloned as a CSF-1-responsive gene in murine macrophages (Matsushime et al., 1991) . It belongs to a family of three closely related D-type cyclins, D1, D2, and D3, that have overlapping functions. Cyclin D1 forms a holoenzyme with a cyclin-dependent kinase (CDK), either CDK4 or CDK6 that phosphorylates the retinoblastoma gene product pRb. Overexpression of cyclin D1 promotes progression through the G 1 phase of the cell cycle in cells grown on substratum (Pestell et al., 1999; Sherr and Roberts, 1999) and overexpression of cyclin D1 but not cyclin E promotes contact-independent growth (Resnitzky and Reed, 1995) . Several recent studies evidence a key role for cyclin D1 in cell-cycle regulation by integrin-mediated adhesion. First, FAK induces cyclin D1 expression after integrin engagement and FAK inhibition by a dominant negative mutant inhibited both cell cycle progression and cyclin D1 expression (Zhao et al., 2001) . Second, the ankyrin repeat-containing serine-threonine kinase, integrin-linked kinase (ILK), which binds the cytoplasmic domain of ␤1 and ␤3 integrin subunits, promotes contact-independent growth and directly induces cyclin D1 expression and transcription (D'Amico et al., 2000) . Finally, disruption of the actin cytoskeleton by cytochalasin D inhibits cyclin D1 expression, consistent with a model in which integrin-dependent organization of the cytoskeleton plays a role in regulating cyclin D1 expression (Bohmer et al., 1996) . Dysregulated expression of cyclins and/or their CDKs can lead to aberrant cellular growth, proliferation, and tumorigenesis. The cyclin D1 gene is amplified or overexpressed in up to 50% of human breast cancers (Dickson et al., 1995; McIntosh et al., 1995) , and its level of overexpression correlates with early onset of disease and risk of tumor progression and metastasis (Jares et al., 1994; Drobnjak et al., 2000) . Consistent with the clinical studies implicating cyclin D1 in breast cancer, transgenic mice overexpressing cyclin D1 in the mammary gland develop mammary cancer (Wang et al., 1994) , whereas mice lacking cyclin D1 are resistant to oncogene-induced tumorigenesis, including Ras-induced skin tumors (Robles et al., 1998) and ErbB2 or Ras-induced mammary tumor formation (Yu et al., 2001 ). Cyclin D1 is also known as the bcl-1 gene, which is commonly translocated to the E enhancer of the immunoglobulin heavy chain gene, resulting in constitutive expression of cyclin D1 in B-cell lymphomas (Withers et al., 1991) . Although transgenic mice expressing cyclin D1 under the transcriptional control of the E enhancer rarely develop spontaneous tumor formation, they display altered lymphoid differentiation in both lineages. E Myc-cyclin D1 double transgenic mice, however, rapidly develop invasive lymphoid malignancies without affecting cell cycle progression, suggesting a cooperative role for cyclin D1 in lymphomagenesis that is cell cycle independent, contributing to tumorigenesis and invasiveness (Bodrug et al., 1994; Lovec et al., 1994) . Because cyclin D1 overexpression correlates with tumor metastasis, we considered a role for cyclin D1 in cellular migration. Because macrophages have been shown to enhance tumor progression and metastasis of primary mouse mammary tumors, we have analyzed primary bone marrow macrophages (BMMs) to assess the role of cyclin D1 in macrophage adhesion, motility, and guided migration.
MATERIALS AND METHODS

Mice
Mice homozygously deleted of the cyclin D1 gene (cyclin D1 Ϫ/Ϫ ) (Sicinski et al., 1995) on a mixed C57Bl/6x129/SvJ background were maintained as described previously . Genotyping was performed on tail genomic DNA by polymerase chain reaction under the following conditions: denaturing at 96°C for 1 min, 94°C for 30 s, annealing at 58°C for 30 s, extension at 72°C 30 s for 30 cycles with a final extension at 72°C for 5 min. The cyclin D1-specific primers were as described in Sicinski et al. (1995) .
Cell Culture
Day 5 BMMs from cyclin D1 ϩ/ϩ and cyclin D1 Ϫ/Ϫ mice were prepared as described previously (Stanley, 1990 ) and cultured in supplemented ␣-modified minimal essential medium (Invitrogen, Carlsbad, CA) containing 15% fetal bovine serum (FBS) (Invitrogen) and 120 ng/ml human recombinant CSF-1 (gift of Chiron, Emeryville, CA). Human kidney 293T cells were maintained in ␣-modified minimal essential medium containing penicillin and streptomycin (100 mg of each/liter) and supplemented with 10% FBS.
Retroviral Production and Infection
pMSCV-IRES-GFP (Persons et al., 1999) and the ecotropic, replication-defective helper virus pSV-⌿ -E-MLV (Muller et al., 1991) cDNAs were gifts of Drs. A.W. Nienhuis (St. Jude Children's Research Hospital, Memphis, TN) and O.N. Witte (University of California Los Angeles, Los Angeles, CA), respectively. The coding region of mouse cyclin D1 cDNA (GenBank S78355) was inserted into the MSCV-IRES-GFP vector at the EcoRI site upstream of the IRES driving expression of GFP. MSCV retroviruses were prepared by transient cotransfection with helper virus into 293T cells, by using calcium phosphate precipitation. The retroviral supernatants were harvested 48 h after transfection (Pear et al., 1993) and filtered through a 0.45-m filter. cyclin D1 ϩ/ϩ and cyclin D1 Ϫ/Ϫ BMMs were incubated with fresh retroviral supernatants in the presence of 120 ng/ml CSF-1 and 4 g/ml polybrene for 24 h, cultured for six more days, and subjected to fluorescence-activated cell sorting ( 
Western Blotting
Forty micrograms of each cell lysate was separated by 10% SDS-PAGE and transferred to polyvinylidene dufluoride membrane. Cyclin D1 expression was assessed by Western blotting with a rabbit Ab3 anti-cyclin D1 antibody (Santa Cruz Biotechnology, Santa Cruz, CA). Equal protein loading was confirmed by blotting with anti-EF1␣ antibody (Edmonds et al., 1996) .
Immunofluorescence Staining
Cells were seeded onto fibronectin-coated glass coverslips (BD Biosciences, Bedford, MA). When 60 -70% confluent, cells were starved of CSF-1 overnight then restimulated with CSF-1 for various times before fixation and immunofluorescence staining as described previously (Pixley et al., 2001) . If two primary antibodies were used, they were added sequentially, and each addition was directly followed by incubation with the respective secondary antibodies. The coverslips were mounted in ProLong antifade kit (Molecular Probes, Eugene, OR), and all samples were examined under an 1X70 inverted microscope (Olympus, Tokyo, Japan) with images recorded using a CH1 cooled charge-coupled device (CCD) camera (Photometrics, Tucson, AZ) (Bailly et al., 2000) . Antibodies used included a polyclonal anti-phosphotyrosine antibody (Transduction Laboratories, Lexington, KY), a monoclonal anti-phosphotyrosine antibody (anti-PTyr; PT66; Sigma-Aldrich, St. Louis, MO), polyclonal anti-Y118 phospho-specific paxillin antibody (BioSource International, Camarillo CA), and a monoclonal anti-␤-tubulin (XIV17.16; gift of Dr. Anne Johnson, Albert Einstein College of Medicine, Bronx, NY)). The expression level of CSF-1 receptor (CSF-1R) was determined by FACS analysis by using the monoclonal AFS98 antibody (Sudo et al., 1995) (a gift of Dr. S. Nishikawa).
Interference Reflection Microscopy (IRM)
IRM was performed using a 60ϫ numerical aperture 1.4 planapo infinity-corrected objective (Nikon, Tokyo, Japan) with a Radiance 2000 confocal microscope (Bio-Rad, Hercules, CA) in reflectance mode with polarization filters at either 488 or 568 nm. Direct adherence or apposition of the cell to the substrate is imaged as black (destructive interference) and greater distance is viewed as white (direct reflection or constructive interference). Image analysis was performed on the images based on the assumption that more adherent cells would have more dark pixels per unit area spread than less adherent cells. I.P. Lab Spectrum software (Scanalytics, Fairfax, VA) was used to manually trace cells and to calculate the proportion of light versus dark pixels per cell. The total area of ventral cell surface apposition to the coverslip and the ratio of closely adherent to loosely adherent areas of the ventral surface were quantitated using NIH Image.
Adhesion Assay
Using fibronectin-coated (human fibronectin; BD Biosciences, Two Oak Park, Bedford, MA), collagen-coated (type I rat tail; Collaborative Biomedical Products, Two Oak Park, Bedford, MA), or regular 24-well plates (BD Biosciences), 5 ϫ 10 4 cells were plated per well in triplicate and allowed to adhere at 37°C for various periods of time. The cells were then gently rinsed twice with warmed phosphatebuffered saline (PBS) and fixed for 7 min in 3.7% formaldehyde, and adherent cells were counted. (To control for cell number, one plate of each genotype was counted after 6 h and the actual cell count was corrected for these values) (Pixley et al., 2001) . Data are expressed as the ratio of the number of adherent cells at each interval divided by the number of cells adherent at 6 h.
Phase Contrast Light Microscopy and Scanning Electron Microscopy (EM)
Cells were plated on fibronectin-coated glass coverslips and grown to 70% confluence. The cells were rinsed with PBS and either fixed for 5 min in 3.7% formaldehyde/PBS for phase contrast studies or, for scanning EM, fixed quickly with 1% osmium tetroxide/0.1 M cacodylate for 5 s at room temperature followed by 2.5% glutaraldehyde/0.1 M cacodylate fixation as described previously (Galbiati et al., 1998; Pixley et al., 2001) , to prevent agonal membrane artifacts. Dehydrated cells were critical point dried by using liquid carbon dioxide in a Samdri 790 critical point drier (Tousimis Research, Rockville, MD), sputter coated with gold-palladium in a Vacuum Desk-1 sputter coater (Denton, Cherry Hill, NJ), mounted, and viewed in a JSM6400 scanning electron microscope (JEOL, Peabody, MA) by using an accelerated voltage of 10 kV for EM.
Spreading Assay
Spreading assays were done as described previously (Oh et al., 1999) . Briefly, cells were starved for 18 h and then plated on 60-mm plastic tissue culture dishes in media containing 10,000 U/ml CSF-1 for the indicated time points. Dark cells were considered to be spread, and bright cells as unspread. Pictures of three independent fields were taken under the 10ϫ objective. Experiments were done in triplicate and repeated three times.
Wound Healing
Cells were plated onto tissue culture dishes and grown to confluence before scoring with a 10-l micropipette tip (Pixley et al., 2001) . Normal medium with CSF-1 was changed immediately after scoring and daily during healing, and the wounds were photographed at intervals until they were occluded by migrating cells.
Chemotaxis
Polycarbonate filters (8.0 m; Osmonics, Westborough, MA) were coated with collagen 1 (12.5 g/ml final concentration; type 1 rat tail, Collaborative Biomedical Products) and a modified 48-well microchemotaxis (Boyden) chamber (Falk et al., 1980) was used to assess chemotactic activity. After overnight removal of CSF-1, cells were lifted by 0.5 mM EDTA, and 2 ϫ 10 4 cells were seeded in each upper well in triplicate in the absence of CSF-1. The lower wells contained medium with either 0, 1.2, or 12 ng/ml CSF-1. The chamber was incubated for 3 h at 37°C, 5% CO 2 . Cells attached to the membrane were fixed with 10% neutral formaldehyde for 3 h and stained with hematoxylin. Cells were counted after washing three times with PBS and wiping off the upper surface of the membrane.
Endothelial Cell Isolation and Transmigration Assay
Pulmonary endothelial cells were isolated from peripheral lung tissue of C57Bl/6 mice after digestion with type 2 collagenase (2 mg/ml; Worthington Biochemicals, Freehold, NY) for 2 h at 37°C, in Ca 2ϩ /Mg 2ϩ -free Krebs-Henseleit buffer (118 mM NaCl, 4.7 mM KCl, 1.2 mM MgSO 4 , 1.2 mM KH 2 PO 4 , 25 mM NaHCO 3 , 11 nM dextrose). Cells were counted, suspended at 1 ϫ 10 7 cells/ml and mixed with magnetic beads coated with Griffona simplicifolia lectin at a ratio of 1:10 for 20 min to purify endothelial cells. Endothelial cell-bead complexes were isolated using a magnetic particle separator, and the endothelial cells were released from the beads by washing twice with 10 mM fucose in complete media (DMEM-F12, 15% FBS, 10 mM l-glutamine, 100 g/ml endothelial cell growth supplement, 10 U/ml heparin). Endothelial cells were then grown on gelatin-coated tissue culture dishes. Endothelial cell purity was determined to be in excess of 95% by using platelet endothelial cell adhesion molecule staining, acylated low density lipoprotein uptake and cobble-stoned morphology.
For the transmigration assay, pulmonary endothelial cells, passage 3 to 5, were plated onto Transwell polycarbonate membranes (3-m pore size; Corning Glassworks, Corning, NY) overnight. The Transwell membranes and the endothelial cell monolayers separate each well into upper and lower chambers. No endothelial cells from the confluent monolayer could be demonstrated in the lower chamber as determined by cell counts from wells receiving no macrophages. The integrity of the endothelial cell monolayers was verified using diffusion of Evans blue-stained bovine serum albumin. Intact monolayers prevented the passage of the dye from the upper to the lower chamber.
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RESULTS
Macrophage Morphology Is Altered by Cyclin D1 Deficiency
Compared with BMMs from wild-type (WT) littermate control mice, BMMs from cyclin D1-deficient mice did not express detectable cyclin D1, whereas MSCV-Cyc D1-expressing cyclin D1 Ϫ/Ϫ (cyclin D1 Ϫ/Ϫ /CycD1) BMMs expressed approximately fivefold greater levels ( Figure 1A ). Phase contrast microscopy of the cyclin D1 Ϫ/Ϫ BMM indicated that, in the presence of CSF-1, they were less polarized and more spread than WT BMMs, and frequently circular in appearance, whereas cyclin D1 Ϫ/Ϫ /CycD1 BMMs resembled WT cells (Figure 1, B-D) . To more closely examine morphological changes such as spreading and dorsal ruffling, scanning EM was carried out and revealed that, in addition to changes in polarization and spreading, cyclin D1 Ϫ/Ϫ BMMs displayed fewer dorsal ruffles than WT BMMs and reexpression of cyclin D1 reproduced WT numbers of dorsal ruffles (Figure 1 , E-G). Because these differences were likely to reflect changes in the actin cytoskeleton, the distribution of F-actin was examined by tetramethylrhodamine B isothiocyanatephalloidin staining. Although macrophages do not contain thick bundles of F-actin, fine F-actin cables that are parallel to the polarized axis of the cell or radially positioned can often be seen (Allen et al., 1997; Pixley et al., 2001) . In cyclin D1 Ϫ/Ϫ BMMs, however, large numbers of circumferential cortical F-actin cables were found (Figure 2, A vs. B) . In contrast to the differences in F-actin staining, ␤-tubulin staining of the microtubule cytoskeleton revealed no differences between WT and cyclin D1 Ϫ/Ϫ BMMs (Figure 2 , E and F), and as expected immunofluorescence staining for cyclin D1 demonstrated the presence of nuclear cyclin D1 in the cyclin D1wt but not the cyclin D1 Ϫ/Ϫ BMMs.
Focal Complexes Are Increased in Cyclin D1-deficient Macrophages
The flattened, unpolarized phenotype of cyclin D1
BMMs suggested that they might be more adherent than WT BMMs. Macrophage focal complexes are usually small in size and number (Allen et al., 1997; Pixley et al., 2001) but are increased when macrophages become more adherent (Pixley et al., 2001) . Although they are more difficult to detect in primary BMMs than macrophage cell lines, phosphotyrosine immunofluorescence staining of WT and cy- 
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Ϫ/Ϫ BMMs shows more phosphotyrosine-rich focal complexes in cyclin D1-deficient BMMs than WT BMMs (Figure 2, C and D) . Paxillin is a focal adhesion protein (Turner, 2000) . On tyrosine phosphorylation, phosphopaxillin has been shown to translocate to focal contacts and dorsal ruffles in normal mammary epithelial cells (Nakamura et al., 2000) . Further immunofluorescence imaging of the BMM focal complexes was carried out using a phospho-specific Y118 anti-paxillin antibody, because phosphoY118 paxillin is localized almost exclusively to focal complexes in macrophages. After 30 min of CSF-1 treatment, when macrophage focal complexes are most pronounced, striking differences could be seen in cyclin D1 Ϫ/Ϫ BMM focal complexes compared with those of WT cells. Cyclin D1-deficient BMMs displayed large numbers of circumferential focal complexes, whereas focal complexes in WT macrophages remained difficult to identify (Figure 3) . CSF-1 receptor expression, as measured by FACS analysis, was similar in the cyclin D1 Ϫ/Ϫ and WT BMMs, indicating that the increase in focal complex tyrosine phosphorylation and phosphorylated paxillin was not attributable to an increase in cell surface CSF-1 receptor expression (our unpublished data).
Spreading and Adhesion Are Increased in Cyclin D1-deficient Macrophages
Increased focal complex number and paxillin tyrosine phosphorylation are associated with increased adhesion in macrophages (Pixley et al., 2001) . As an indirect measure of macrophage adhesion, IRM was used to determine appositional proximity. IRM, which displays areas of close contact with the substratum as dark gray and regions less closely apposed as white, has been widely used to measure adhesion in a variety of cell types (Zand and Albrecht-Buehler, 1989; Bailly et al., 1998) . In cycling WT, cyclin D1 Ϫ/Ϫ , and cyclin D1 Ϫ/Ϫ /CycD1 BMM, IRM analysis of cell spreading revealed that the WT and cyclin D1 Ϫ/Ϫ /CycD1 cells were similarly spread, whereas cyclin D1 Ϫ/Ϫ BMM displayed significantly larger footprints (our unpublished data), consistent with their flattened phenotype ( Figure 1F ). Further IRM analysis was carried out on WT and cyclin D1 Ϫ/Ϫ BMMs that had been starved of CSF-1 overnight followed by CSF-1 stimulation for 0 or 15 min. In the absence of CSF-1, cyclin D1 Ϫ/Ϫ BMMs were significantly more adherent than WT BMMs (Figure 4, A, B , and E). Because CSF-1 stimulation promotes macrophage spreading and adhesion (Boocock et al Pixley et al., 2001) , the effect of CSF-1 on BMM apposition was determined. In contrast to WT BMMs, the CSF-1-induced increase in spreading and close apposition was not apparent in cyclin D1 Ϫ/Ϫ BMMs (Figure 4 , A-F). Indeed, cyclin D1 Ϫ/Ϫ BMMs seemed to be constitutively well spread and closely adherent
To further investigate the effect of cyclin D1 deficiency on macrophage spreading and adhesion, the ability of WT and cyclin D1 Ϫ/Ϫ BMMs to spread after replating was measured.
Cyclin D1
Ϫ/Ϫ BMMs spread significantly more rapidly than WT BMMs at 1 and 3 h, as judged by the ratio of dark to bright cells under phase contrast ( Figure 5A ). This difference had decreased by 5 h and, after 24 h, almost all cells were spread. Thus, cyclin D1-deficient macrophages spread more rapidly than control cells. As a more direct measure of cell adhesion, the ability of replated WT and cyclin D1 Ϫ/Ϫ BMMs to maintain adhesion on tissue culture plastic, fibronectin, or collagen in the presence of a disrupting force was assessed. Cyclin D1-deficient macrophages were more adherent than WT BMMs on all surfaces at all time points investigated ( Figure 5B ).
These studies demonstrate that cyclin D1 deficiency leads to increased macrophage spreading and adhesion in response to both CSF-1-and integrin-mediated stimulation.
Cyclin D1 ؊/؊ Macrophages Display Decreased Motility
Because increased adhesion and loss of polarity is associated with decreased motility, WT and cyclin D1 Ϫ/Ϫ BMM were subjected to a wound healing assay. WT BMMs migrated into the wound and closed it within 24 h, whereas cyclin D1-deficient BMMs were significantly less motile ( Figure  6A ). Motility of cyclin D1 Ϫ/Ϫ /CycD1 BMMs approximated the motility of WT cells. Overnight time-lapse videomicroscopy was also performed to assess wound closure at 10-min intervals in WT and cyclin D1 Ϫ/Ϫ BMMs. The mean rate of closure, measured as uncovered area, was delayed in the Ϫ/Ϫ BMMs were plated on fibronectincoated coverslips and, after overnight removal of CSF-1, stimulated with CSF-1 for the times indicated. Cells were stained for phosphoY118 paxillin and examined by cooled CCD microscopy (60ϫ).
cyclin D1-deficient BMMs ( Figure 6B , side-by-side-b.mov). Increased expression of a protein tyrosine phosphatase, PTP, has been shown to reduce adhesion and increase motility in macrophages by disrupting focal complex formation (Pixley et al., 2001) . Consistent with this, the levels of PTP in cyclin D1 Ϫ/Ϫ BMMs were reduced to ϳ50% of WT levels (our unpublished data).
Cyclin D1-deficient Macrophages Are Defective in Both Chemotaxis and Transmigration to CSF-1
A modified Boyden chamber assay was carried out to determine whether the chemotactic response to CSF-1 was also altered in cyclin D1 Ϫ/Ϫ BMMs. The chemotactic responses of WT and cyclin D1 Ϫ/Ϫ BMMs were equivalent at low concentrations of CSF-1 ( Figure 7A ). However, a further increase in the response at higher concentrations was only observed for the WT cells ( Figure 7A ), indicating a role for cyclin D1 in CSF-1-induced macrophage chemotaxis. Because chemotaxis assays are not influenced by proliferative rates these findings further support the conclusion that cyclin D1 affects migration independently of a cellcycle function.
The increased adhesion and decreased motility of cyclin D1 Ϫ/Ϫ macrophages suggest that their ability to transmigrate through an endothelial cell barrier would also be diminished. WT and cyclin D1-deficient BMMs were exposed to different concentrations of CSF-1, and migration across a pulmonary primary endothelial cell layer was assessed. Transmigration of cyclin D1 Ϫ/Ϫ BMMs to high CSF-1 concentrations was significantly reduced compared with WT BMMs. As for the chemotactic response, the transmigration defect was concentration dependent ( Figure 7B ). 
DISCUSSION
A growing literature indicates important roles for cyclin D1 in diverse physiological and pathological processes. Cyclin D1 regulates normal cell cycle progression and differentiation (Sherr, 1996; Pestell et al., 1999; Sherr and Roberts, 1999) (reviewed in Fu et al., 2002) , and its overexpression is associated with a variety of neoplasias, including centrocytic lymphoma and breast cancer (Bodrug et al., 1994; WeinstatSaslow et al., 1995; Donnellan and Chetty, 1998) . In addition to its key role in cell cycle regulation and differentiation, overexpression of cyclin D1 is associated with a cell cycleindependent increase in tumor invasiveness and metastasis (Bodrug et al., 1994; Jares et al., 1994; Lovec et al., 1994) . Delineating these additional functions of cyclin D1 may contribute to a more fundamental understanding of the pathogenesis and progression of tumors in which cyclin D1 is overexpressed. In the present study, we have shown that cyclin D1-deficient macrophages have an altered morphology, increased adhesion, and decreased motility and chemotaxis toward CSF-1.
Cyclin D1 deficiency confers a dramatic morphological phenotype that overrides the significant CSF-1-regulated morphological changes observed in WT macrophages (Figure 1) (Boocock et al., 1989; Pixley et al., 2001) . Cyclin D1 Ϫ/Ϫ macrophages are constitutively well spread and attached (Figure 4) , and their attachment is mediated via increased numbers of circumferentially arrayed focal complexes rich in phosphoY118 paxillin (Figure 3) . The circumferential arrangement of these adhesion sites is associated with a closely aligned distribution of multiple cortical F-actin cables (Figure 2 ). On replating in the presence of CSF-1, Cyclin D1 Ϫ/Ϫ BMMs also demonstrate an ability to adhere more firmly and to spread more rapidly ( Figure 5 ). This increased adherence is consistent with their reduced motility in the wound-healing assay ( Figure 6 ) and reduced chemotaxis toward CSF-1 through membrane and endothelial cell barriers ( Figure 7) . Reexpression of cyclin D1 in cyclin D1 Ϫ/Ϫ BMMs leads to reversion of the morphological, adhesion, and motility changes to produce cells that resemble WT BMMs, indicating that the phenotype is a consequence of the loss of cyclin D1.
Macrophages are highly motile and respond to a variety of different adhesion and motility signals through complex signaling pathways, including G protein-coupled receptor pathways, receptor tyrosine kinase pathways, and integrinmediated signaling. Macrophage motility is enhanced by the Src family tyrosine kinases and pathways that activate FAK or Pyk2 (Lowell and Berton, 1999; Jones, 2000) . Activation of the CSF-1R and integrins results in the sequential tyrosine phosphorylation and translocation of several proteins to the focal complexes, including paxillin and FAK (Allen et al., 1997) , leading to increased focal complex formation and adhesion (Richardson et al., 1997; Hagel et al., 2002) , followed by cellular polarization, disengagement from the substratum, and directed migration (Jones, 2000) . These morphological changes result from CSF-1-and integrin-induced . Transendothelial migration of BMMs was assessed using a pulmonary endothelial monolayer. Wild-type and cyclin D1-deficient BMMs were exposed to CSF-1 at the concentrations indicated. activation of the Rho GTPases, Rac, Rho, and Cdc42, which stimulate actin polymerization and are required for CSF-1-induced migration (Allen et al., 1998; Vanhaesebroeck et al., 1999; Jones, 2000) . In addition, the protein tyrosine phosphatase, PTP, disrupts macrophage focal complexes by dephosphorylating paxillin, thereby reducing its incorporation into nascent focal complexes (Pixley et al., 2001) . In a physiological context, monocyte/macrophage transmigration through endothelial cells is the initial step in the recruitment of macrophages into areas of tissue damage/infection, as well as for transmigration into tumors. After adhering to the surface of the endothelial cells, the migrating cell must penetrate the endothelial junction and undergo cytoskeletal reorganization. In the case of melanoma cells, the penetration of the endothelial junction is initiated by pseudopodia (Ballestrem et al., 2000) . Transendothelial cell migration requires multiple adhesive interactions with the endothelial cells and correlates with the metastatic potential of tumor cells (Ridley, 2001; Voura et al., 1998 Voura et al., , 2001 . The finding that cyclin D1 deficiency retards transendothelial cell migration supports a model in which cyclin D1 may contribute directly to the metastatic phenotype.
Growing evidence supports a role for chemokines in tumor progression and metastasis (Murphy, 2001) . Elevated expression of CSF-1 and c-fms (CSF-1R) is associated with poor prognosis in several epithelial cancers, including breast, uterus, ovary, and prostate (Kacinski, 2002) . CSF-1, probably via macrophage recruitment and regulation, plays a role in the progression and metastasis of mammary carcinoma in transgenic mice induced by mammary gland-targeted Polyoma middle t antigen. Mice containing a recessive null mutation in the CSF-1 gene (CSF-1 OP ) are resistant to the induction of mammary tumors and lack the mammary gland macrophage infiltration observed in the CSF-1 wildtype littermate controls (Lin et al., 2001) . Furthermore, treatment with CSF-1 antisense oligonucleotides of mice bearing transplanted metastatic tumors inhibits tumor growth and angiogenesis and increased survival (Aharinejad et al., 2002) . Consistent with the important role of macrophages in the onset and progression of mammary tumorigenesis (Coussens and Werb, 2001) , the reduced migration of macrophages derived from the mammary tumor-resistant cyclin D1 Ϫ/Ϫ mice (Yu et al., 2001) , suggests that this macrophage motility defect may contribute to the tumor resistance in these mice. It will be of importance to determine whether cyclin D1 abundance contributes to chemokine induced migration in other cell types. Our studies in cyclin D1 Ϫ/Ϫ mouse embryo fibroblasts and endothelial cells also demonstrated reduced migration (Pestell and Neumeister, unpublished data) , suggesting the migratory function observed in BMMs may be a more general function of cyclin D1.
What are the implications of these studies for understanding the role of cyclin D1 in oncogenesis ? First, because cyclin D1 reduced adhesion to cellular surfaces and enhanced guided cell motility and migration of primary BMMs, this function of cyclin D1 may be relevant to hematopoetic malignancies. Cyclin D1 is also known as the bcl-1 gene, which is commonly translocated to the E enhancer of the immunoglobulin heavy chain gene. The cyclin D1 translocation results in constitutive expression in B-cell lymphomas (Withers et al., 1991) . Transgenic mice expressing cyclin D1 under the transcriptional control of the E enhancer showed altered lymphoid differentiation but rarely develop spontaneous tumors; however, E Myc-cyclin D1 double transgenic mice developed invasive lymphoid malignancies without affecting the cell cycle (Bodrug et al., 1994; Lovec et al., 1994) . Thus, the current studies suggest that cyclin D1 overexpression in hemopoietic malignancies could contribute to the invasiveness and/or metastatic phenotype, independently of effects on proliferation, by regulating cellular adhesiveness. Second, because cyclin D1 overexpression correlates with invasive and metastatic phenotype in several cell types (Jares et al., 1994; Drobnjak et al., 2000) , and cyclin D1 enhances migration in several distinct cell types, the abundance of cyclin D1 may contribute directly to cellular metastasis and invasiveness through the effects on cellular adhesion we describe. Third, as dynamic adhesion to the cellular substratum contributes through integrin engagement to aberrant cellular survival, and cyclin D1 abundance regulates the dynamics of cellular adhesion, cyclin D1 may also contribute to cellular growth properties through regulating cellular substratum interactions. Integrin engagement and perhaps the resulting mechanical force generated, contribute to growth signaling pathways by activating members of the Rho family and thereby to cell survival pathways, including extracellular signal-regulated kinase, phosphatidylinositol-3 kinase, and Akt (Parise et al., 2000) . Cyclin D1-deficient cells exhibit increases apoptosis on several different substrata . The dissection of the independent contribution of cyclin D1 to survival via its effects on adhesion versus effects on driving oncogenic growth and thereby decreasing adhesion may be challenging, because several oncogenes that induce cyclin D1 also decrease adhesion. For example, epithelial cells transformed by oncogenic Rac, which induces cyclin D1 (Westwick et al., 1997) , acquire a mesenchymal phenotype with decreased cell-cell adhesion and stress fibers (Zhong et al., 1997; Zondag et al., 2000) .
